GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Arcutis Biotherapeutics
Arcutis is a biopharmaceutical company specializing in the treatment of dermatological diseases. Its stock price reflects the commercial success of its drugs and the potential for expansion, which is a key driver of its growth.
Share prices of companies in the market segment - Pharma skin
Arcutis is a biopharmaceutical company specializing in the treatment of dermatological diseases. Its business consists of this segment alone. We classify it as belonging to the Pharma Skin sector, and the chart below shows the general dynamics of biotech companies, where value is determined by the success of drug commercialization.
Broad Market Index - GURU.Markets
Arcutis Biotherapeutics is a dermatology company developing innovative drugs for the treatment of skin conditions. Its focus on this niche makes it a prominent player in the GURU.Markets index. The chart below represents the entire market. Find out how Arcutis compares to the overall market dynamics.
Change in the price of a company, segment, and market as a whole per day
ARQT - Daily change in the company's share price Arcutis Biotherapeutics
For Arcutis, a biopharmaceutical company specializing in dermatology, change_co is a measure of reaction to clinical and commercial news. Daily fluctuations reflect the volatility associated with new product launches. This metric is a key element in analyzing young biotech companies on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Pharma skin
Arcutis Biotherapeutics, Inc. is a biotech company. This chart highlights the extreme volatility of the sector. Comparison with ARQT, which focuses on dermatology, helps us assess it as a high-risk, clinical-data-driven asset.
Daily change in the price of a broad market stock, index - GURU.Markets
Arcutis is a biopharmaceutical company specializing in skin treatments. Dermatology is a competitive segment of the pharmaceutical industry. The chart below shows the average volatility in this niche, allowing investors to compare Arcutis's stock performance with other companies in the sector.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Arcutis Biotherapeutics
Arcutis is a biopharmaceutical company focused on dermatology. Its year-over-year performance reflects both the commercial success of its existing drugs and investor confidence in its R&D platform, which is focused on new breakthrough products.
Annual dynamics of market capitalization of the market segment - Pharma skin
Arcutis Biotherapeutics, Inc. is a commercial biopharmaceutical company focused on developing and marketing treatments for skin diseases. The chart shows how its success in commercializing new products and competition in the large dermatology market impact its performance relative to the pharmaceutical sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Arcutis is a biopharmaceutical company whose stock performance is driven by the success of its drug sales and progress in research. The company's business is not dependent on economic cycles. The chart reflects biotech events rather than macroeconomic data, making it a non-cyclical growth story.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Arcutis Biotherapeutics
Arcutis, a biopharmaceutical company specializing in the treatment of dermatological diseases. The monthly fluctuations on the chart reflect the commercial success of its approved drugs and news about clinical trials.
Monthly dynamics of market capitalization of the market segment - Pharma skin
Medical dermatology is a promising segment of the pharmaceutical market, where success depends on the commercialization of new drugs. The dynamics of this sector, shown in the chart, reflect investors' confidence in the potential of new skin treatments. This is the backdrop against which Arcutis Biotherapeutics is bringing its products to market.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Arcutis Biotherapeutics is a biotech company focused on dermatology. Its stock follows its own unique pattern, driven primarily by news of clinical trials and drug approvals. Therefore, its monthly performance often doesn't correlate with the market, showing sharp ups and downs driven by company-specific events.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Arcutis Biotherapeutics
Arcutis Biotherapeutics is a commercial biopharmaceutical company focused on dermatology. Its weekly stock price is driven by sales reports for its approved drugs for psoriasis and other skin conditions, as well as news on clinical trials of new candidates.
Weekly dynamics of market capitalization of the market segment - Pharma skin
Arcutis, as a commercial biopharmaceutical company with a single core product, can move differently than diversified giants. The successful launch and sales growth of its drug is a unique driver. The chart allows for comparison with the broader pharmaceutical sector and shows how the market values a growth story focused on a single drug.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Arcutis is a biopharmaceutical company specializing in dermatology. Its success depends on the commercialization of new drugs. The chart shows how its stock, as a growth story in a narrow niche, moves independently of overall market trends.
Market capitalization of the company, segment and market as a whole
ARQT - Market capitalization of the company Arcutis Biotherapeutics
Arcutis Biotherapeutics' market capitalization reflects investor expectations for its portfolio of dermatological treatments. Its price chart shows how investors are reacting to the commercial launch of its first product and data on other developments. This is an assessment of its ability to carve out a significant niche in the competitive field of dermatology.
ARQT - Share of the company's market capitalization Arcutis Biotherapeutics within the market segment - Pharma skin
Arcutis Biotherapeutics is seeking to capture its share of the dermatology market by developing new treatments for skin diseases. Its market capitalization is based on the potential of its drugs to offer more effective and safer solutions for millions of patients.
Market capitalization of the market segment - Pharma skin
Here's a chart showing the market capitalization of the dermatology pharmaceutical sector. Arcutis Biotherapeutics is a company focused on developing new treatments for skin diseases. The potential of this market is enormous, as millions of people suffer from conditions like psoriasis. Arcutis strives to offer them more effective and convenient solutions.
Market capitalization of all companies included in a broad market index - GURU.Markets
Arcutis Biotherapeutics is a company focused on developing new treatments for dermatological diseases. Its market capitalization is driven by innovation in skin care. The chart below shows the economic weight of the medical dermatology and cosmetology sector.
Book value capitalization of the company, segment and market as a whole
ARQT - Book value capitalization of the company Arcutis Biotherapeutics
Arcutis Biotherapeutics' foundation is its intellectual property in its portfolio of dermatological drugs, primarily its commercial product, ZORYVE. This chart tells the story of the company's transformation from the R&D stage to the commercial stage, where revenue from its first product begins to form a solid financial and material basis for further development.
ARQT - Share of the company's book capitalization Arcutis Biotherapeutics within the market segment - Pharma skin
Arcutis Biotherapeutics focuses on dermatology. The chart shows its share of actual R&D assets. These are its laboratories where new drugs for treating skin diseases are developed and tested, with the goal of offering patients more convenient and effective solutions.
Market segment balance sheet capitalization - Pharma skin
Arcutis Biotherapeutics is a commercial biopharmaceutical company, making it moderately capital-intensive. In addition to R&D, it is building a commercial infrastructure to market its dermatological drugs. Compared to the biotech sector, it is heavier than early-stage companies but lighter than established giants.
Book value of all companies included in the broad market index - GURU.Markets
Arcutis's assets are scientific capital focused on developing a new generation of treatments for skin conditions, from psoriasis to eczema. The company's balance sheet reflects the value of its innovative developments. The chart shows the volume of resources invested in dermatology to offer patients more convenient and effective solutions.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Arcutis Biotherapeutics
Arcutis Biotherapeutics is a dermatology company. Its market value is based on the potential of its skin treatments. Investors evaluate not current assets but future cash flows from sales if the drugs are successful. The break in the graph represents a premium for innovation in a sought-after medical field.
Market to book capitalization ratio in a market segment - Pharma skin
Arcutis Biotherapeutics specializes in dermatology drugs. Its value depends almost entirely on the success of one or more key products. This chart illustrates a classic biotech scenario: market valuation reflects peak sales of future drugs, not current tangible assets.
Market to book capitalization ratio for the market as a whole
Arcutis Biotherapeutics is a pharmaceutical company specializing in dermatology. Its market capitalization is based on the potential of its skin treatments. This chart demonstrates how a biotech company's market valuation can be detached from its book value, reflecting expectations for the commercial success of its products.
Debts of the company, segment and market as a whole
ARQT - Company debts Arcutis Biotherapeutics
Arcutis Biotherapeutics is a dermatology company developing innovative treatments for skin diseases. Funding clinical trials and preparing for the commercial launch of products requires significant resources. This chart shows how the company raises capital to advance its mission in medical dermatology.
Market segment debts - Pharma skin
Arcutis Biotherapeutics is a biopharmaceutical company specializing in dermatology. After launching its first product, its funding focus shifts to marketing and sales. This chart shows how the company funds commercialization to compete in the large and competitive skin treatment market.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Arcutis Biotherapeutics
Arcutis Biotherapeutics is a biopharmaceutical company specializing in the development and commercialization of drugs for the treatment of dermatological diseases. This chart shows its financial position at the product launch stage. The company's capital is used to build a commercial team and for marketing purposes to promote its innovative creams and ointments.
Market segment debt to market segment book capitalization - Pharma skin
Arcutis Biotherapeutics is a dermatology company developing new treatments for skin diseases. The chart shows the overall debt burden in the specialty pharmaceuticals sector. It provides insight into how the company's financial strategy for funding clinical trials and product launches is typical for this competitive niche.
Debt to book value of all companies in the market
Arcutis Biotherapeutics, as a biotech company, relies on equity capital. The chart shows the total debt burden for the entire economy. It clearly illustrates two different worlds: the world of mature companies, which manage debt based on credit cycles, and the world of innovation, where funding depends on scientific advances.
P/E of the company, segment and market as a whole
P/E - Arcutis Biotherapeutics
For Arcutis Biotherapeutics, which focuses on dermatology, this chart evaluates its ability to bring new skin treatments to market. The price-to-earnings ratio reflects investor expectations for the commercial success of its drugs. The price-to-earnings ratio reflects the market's reaction to trial data and regulatory decisions.
P/E of the market segment - Pharma skin
This chart reflects the average valuation for the speculative biotech sector—a benchmark for Arcutis. For investors, it serves as a benchmark, reflecting the overall level of optimism in the industry. Against this backdrop, one can gauge expectations for Arcutis's developments in the less risky but competitive field of dermatology.
P/E of the market as a whole
Arcutis Biotherapeutics specializes in the development and commercialization of drugs for the treatment of dermatological diseases. The company is bringing new products to market and seeks recognition from doctors and patients. This chart of overall biotech risk appetite shows how willing investors are to fund expensive marketing efforts and believe in the commercial potential of Arcutis's drugs.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Arcutis Biotherapeutics
Arcutis Biotherapeutics is a biopharmaceutical company specializing in the development of treatments for dermatological diseases. Its future depends on the commercial success of its products. This chart shows analysts' forecasts for the sales volume of its creams and the company's ability to capture a significant share of the psoriasis and eczema treatment market.
%20P%2FE%20Arcutis%20Biotherapeutics&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Arcutis-Biotherapeutics&v=1772513860263 "Chart of the company's future (projected) P/E Arcutis Biotherapeutics")
Future (projected) P/E of the market segment - Pharma skin
Arcutis Biotherapeutics is a biopharmaceutical company specializing in the development and commercialization of treatments for dermatological diseases. Its valuation relative to other biotech companies reflects investor expectations for its drug portfolio. A high valuation may reflect a belief that its products will become leaders in the large dermatology market.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-skin&v=1772513860269 "Future (projected) P/E graph of the market segment - Pharma skin")
Future (projected) P/E of the market as a whole
Arcutis Biotherapeutics is a biopharmaceutical company specializing in dermatology. It is launching new drugs to treat conditions such as psoriasis and atopic dermatitis. This chart shows the overall market sentiment that influences the valuation of young commercial biopharmaceuticals. It reflects investor confidence in the success of new product launches.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513860285 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Arcutis Biotherapeutics
Arcutis Biotherapeutics is a dermatology company focused on developing and commercializing treatments for skin diseases. The financial metrics presented in this chart depend on the market success of its products. Effective sales and marketing, as well as securing approvals for new indications, are key to its growth.
Profit of companies in the market segment - Pharma skin
Arcutis Biotherapeutics is a dermatology company developing innovative drugs for the treatment of skin diseases. This chart shows the overall profitability of pharmaceutical companies specializing in dermatology. It helps understand the commercial viability of this market, taking into account competition and the costs of launching new products.
Overall market profit
Arcutis Biotherapeutics is a biopharmaceutical company specializing in dermatology. It brings new drugs to market for the treatment of skin diseases. Its success depends on the commercial launch of its products and their acceptance by the medical community. This is a growth story in a specific medical niche, which is weakly affected by the macroeconomic cycles visible in this chart.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Arcutis Biotherapeutics
Arcutis Biotherapeutics is a dermatology company focused on developing innovative treatments for skin diseases. Its future profit projections depend on the commercial success of its drugs and progress in clinical trials. This chart shows how analysts assess the potential of its products to become new standards in the treatment of psoriasis and other skin conditions.
%20profit%20of%20the%20company%20Arcutis%20Biotherapeutics&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Arcutis-Biotherapeutics&v=1772513860315 "Graph of future (projected) profit of the company Arcutis Biotherapeutics")
Future (predicted) profit of companies in the market segment - Pharma skin
Arcutis Biotherapeutics is a biopharmaceutical company focused on developing and commercializing innovative treatments for dermatological diseases. This chart shows forecasts for the skin pharmaceuticals segment. It provides investors with context for assessing Arcutis' potential to address the needs of patients with conditions such as psoriasis and atopic dermatitis.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-skin&v=1772513860320 "Graph of future (predicted) profits of companies in a market segment - Pharma skin")
Future (predicted) profit of the market as a whole
Arcutis Biotherapeutics is a biopharmaceutical company specializing in dermatology. The overall economic backdrop reflected in this forecast impacts the investment climate. Market optimism facilitates raising capital to fund clinical trials and commercialize new drugs for the treatment of skin diseases, which is Arcutis' primary focus.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513860331 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Arcutis Biotherapeutics
Arcutis Biotherapeutics is a dermatology company developing and commercializing new treatments for skin conditions. This chart shows how investors view its early sales and potential for capturing share in the large prescription skincare market.
P/S market segment - Pharma skin
Arcutis Biotherapeutics is a dermatology company focused on developing innovative treatments for skin diseases. This chart shows the average valuation in the pharmaceutical sector. It reflects investor expectations for the potential of Arcutis's drugs for treating common conditions such as psoriasis and atopic dermatitis.
P/S of the market as a whole
Arcutis Biotherapeutics is a biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases. The company's revenue depends on the success of its drugs for the treatment of psoriasis, dermatitis, and other skin conditions. This chart provides investors with a general framework for assessing the prospects and risks in the specialty pharmaceutical industry.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Arcutis Biotherapeutics
Arcutis Biotherapeutics is a dermatology company developing and commercializing treatments for skin diseases. Future revenue depends on the successful sales of its approved drugs. The chart shows how the market perceives the commercial potential of its products and its ability to capture a significant share of the competitive dermatology market.
%20P%2FS%20Arcutis%20Biotherapeutics&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Arcutis-Biotherapeutics&v=1772513860405 "The graph of the company's future (projected) P/S Arcutis Biotherapeutics")
Future (projected) P/S of the market segment - Pharma skin
Arcutis Biotherapeutics is a dermatology company developing innovative treatments for skin conditions such as psoriasis and atopic dermatitis. It strives to offer more convenient and effective medications. This chart shows how investors assess the commercial potential of its developments compared to other pharmaceutical companies.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20skin&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-skin&v=1772513860409 "Future (projected) P/S market segment graph - Pharma skin")
Future (projected) P/S of the market as a whole
This chart reflects investor appetite for innovation in dermatology. For Arcutis Biotherapeutics, which develops drugs to treat skin conditions, it's an indicator of the investment climate. Market optimism allows the company to attract capital to bring new, more effective, and safer treatments for psoriasis, eczema, and other conditions to market.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513860430 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Arcutis Biotherapeutics
Arcutis Biotherapeutics is a dermatology company focused on developing and commercializing innovative treatments for skin diseases. This chart shows the revenue from sales of its approved drugs. Sales growth reflects the successful launch of new therapeutic options for patients with conditions such as psoriasis and atopic dermatitis.
Sales of companies in the market segment - Pharma skin
Arcutis Biotherapeutics is a biopharmaceutical company focused on the development and commercialization of innovative treatments for dermatological diseases. This chart shows the size of the skin care market. Arcutis aims to address the unmet needs of patients with conditions such as psoriasis and atopic dermatitis.
Overall market sales
Arcutis Biotherapeutics is a biopharmaceutical company focused on dermatology. Its success depends on the approval and commercialization of new drugs for the treatment of skin diseases. The overall economic situation, shown in this chart, affects the availability of capital for research and the ability of the healthcare system to finance innovative drugs.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Arcutis Biotherapeutics
Arcutis Biotherapeutics is a dermatology company focused on the development and commercialization of innovative treatments for skin diseases. Its success depends on the approval and market acceptance of its products. This chart shows analyst expectations for the commercial potential of Arcutis's portfolio and the size of its addressable market in dermatology.
%20sales%20of%20the%20company%20Arcutis%20Biotherapeutics&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Arcutis-Biotherapeutics&v=1772513860565 "Schedule of future (projected) sales of the company Arcutis Biotherapeutics")
Future (projected) sales of companies in the market segment - Pharma skin
Arcutis Biotherapeutics is a biopharmaceutical company specializing in the development and commercialization of treatments for dermatological diseases. This forecast outlines expectations for the pharmaceutical skincare segment, helping to understand the potential market growth expected from new, more effective, and safer drugs.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-skin&v=1772513860624 "Schedule of future (projected) sales of companies in the market segment - Pharma skin")
Future (projected) sales of the market as a whole
Arcutis Biotherapeutics is a biopharmaceutical company specializing in the development and commercialization of treatments for dermatological diseases. Its success depends on regulatory approval and market acceptance of its innovative creams and ointments. The overall economic situation, reflected in this chart, influences consumer spending on health and beauty, as well as biotech investment.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513860663 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Arcutis Biotherapeutics
Arcutis Biotherapeutics is a pharmaceutical company specializing in the development and commercialization of treatments for dermatological diseases. This chart reflects its financial performance at the product launch stage. Profitability depends on the successful launch of new creams and ointments and their acceptance by both physicians and patients.
Market segment marginality - Pharma skin
Arcutis Biotherapeutics is a biopharmaceutical company specializing in the development and commercialization of treatments for dermatological diseases. Profitability will depend on the successful launch of its products. This chart reflects the company's current operational structure and its R&D investment compared to other companies in the dermatology field.
Market marginality as a whole
Arcutis Biotherapeutics is a dermatology company developing innovative drugs for the treatment of skin diseases. This overall market profitability graph is irrelevant to the company. Arcutis's success and future profitability depend on the results of clinical trials, regulatory approval, and the ability to offer patients more effective and convenient treatments.
Employees in the company, segment and market as a whole
Number of employees in the company Arcutis Biotherapeutics
Arcutis Biotherapeutics is a dermatology company focused on treating skin diseases. The graph shows the team bringing innovative drugs to market. Employee growth, particularly in the commercial unit, is a key indicator of successful commercialization and market share.
Share of the company's employees Arcutis Biotherapeutics within the market segment - Pharma skin
Arcutis Biotherapeutics is focused on developing innovative treatments for dermatological diseases. This chart shows the percentage of leading dermatologists, biologists, and clinicians in this therapeutic area that the company attracts. It reflects the concentration of scientific expertise needed to create new treatments for millions of patients with skin diseases.
Number of employees in the market segment - Pharma skin
Arcutis Biotherapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative treatments for dermatological diseases. Its goal is to address the unmet needs of patients with skin diseases. This chart shows employment in the dermatological pharmaceutical sector, which is growing due to the emergence of new, more effective and safer treatments.
Number of employees in the market as a whole
Arcutis Biotherapeutics is a biopharmaceutical company focused on dermatology. They develop new treatments for skin diseases. Their work exemplifies how highly specialized scientific research leads to the creation of new products and markets. They create a demand for highly qualified research scientists and medical specialists.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Arcutis Biotherapeutics (ARQT)
Arcutis Biotherapeutics is a dermatology company developing and commercializing new treatments for skin diseases. This chart shows how the market values this specialty pharmaceutical company. Its high market capitalization per employee reflects the success of its products and its potential to capture a share of the multi-billion dollar dermatology market.
%20of%20the%20company%20Arcutis%20Biotherapeutics%20(ARQT)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Arcutis-Biotherapeutics-ARQT&v=1772513860952 "Chart of market capitalization per employee (in thousands of dollars) of the company Arcutis Biotherapeutics (ARQT)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma skin
Arcutis Biotherapeutics (ARQT) is a biopharmaceutical company specializing in the development and commercialization of treatments for dermatological (skin) diseases. This chart shows the average market capitalization per employee in the sector. It helps assess how the market values their R&D portfolio and commercial launches of dermatological drugs per employee.
%20by%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-skin&v=1772513860986 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma skin")
Market capitalization per employee (in thousands of dollars) for the overall market
Arcutis Biotherapeutics is a dermatology company developing innovative treatments for skin diseases. This chart reflects the market value of one employee, highlighting the company's high appreciation for scientific potential and innovation in its specialized medical field.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513861004 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Arcutis Biotherapeutics (ARQT)
Arcutis Biotherapeutics is a dermatology company with an approved product (psoriasis cream). This graph shows how effectively their small but focused team (R&D and sales) can commercialize their product. It reflects how much net profit each employee generates from sales of this high-margin drug.
%20Chart%20Arcutis%20Biotherapeutics%20(ARQT)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Arcutis-Biotherapeutics-ARQT&v=1772513861015 "Company Profit Per Employee (in thousands of dollars) Chart Arcutis Biotherapeutics (ARQT)")
Profit per employee (in thousands of dollars) in the market segment - Pharma skin
Arcutis (ARQT) is an R&D biotech (dermatology). This chart shows the benchmark for "Pharma" (R&D). The average profit per employee in this sector (venture R&D) is *negative*. This benchmark reflects the "burning" of money in the hopes of one or two mega-successes. The entire sector is an R&D race, spending billions on elite scientists.
%20in%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-skin&v=1772513861045 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma skin")
Profit per employee (in thousands of dollars) for the market as a whole
Arcutis Biotherapeutics is a biopharmaceutical company focused on dermatology (treatment of skin diseases). They already have approved products. This chart shows how successfully their commercial team is selling new drugs (for example, Zoryve). It reflects the balance between R&D expenses (new indications) and growing sales revenue.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513861049 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Arcutis Biotherapeutics (ARQT)
Arcutis Biotherapeutics is a biopharmaceutical company specializing in dermatology. This graph shows the path from development to commercialization. Growth in this indicator will indicate the successful launch of new skin treatments and the company's ability to effectively monetize them.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Arcutis-Biotherapeutics-ARQT&v=1772513861071 "Sales chart per company employee Arcutis Biotherapeutics (ARQT)")
Sales per employee in the market segment - Pharma skin
Arcutis Biotherapeutics is a commercial biotechnology company focused on developing and commercializing dermatological treatments. This chart shows the average revenue per employee in this segment. It allows us to assess how productive Arcutis' R&D and commercialization team is in the dermatology niche compared to its competitors.
Sales per employee for the market as a whole
Arcutis Biotherapeutics is a dermatology company in the early stages of commercializing its products. They recently began generating revenue. This chart is becoming increasingly important. It demonstrates how effectively their new sales team is beginning to conquer the market and convert years of R&D into real revenue from sales of their innovative creams and ointments.
Short shares by company, segment and market as a whole
Shares shorted by company Arcutis Biotherapeutics (ARQT)
Arcutis Biotherapeutics specializes in dermatology, bringing new drugs to market for the treatment of psoriasis and other skin conditions. The company's success depends on how quickly doctors begin prescribing its new creams. This chart shows how many investors doubt the commercial potential of the drugs or fear strong competition.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Arcutis-Biotherapeutics-ARQT&v=1772513861104 "Short Shares Chart for the Company Arcutis Biotherapeutics (ARQT)")
Shares shorted by market segment - Pharma skin
Arcutis Biotherapeutics is a biopharmaceutical company focused on dermatology. They develop and commercialize new treatments for skin diseases such as psoriasis. This chart shows the overall short position in the dermatology biotech sector. Its rise reflects investor doubts about the commercial success of new drugs in this competitive niche.
Shares shorted by the overall market
Arcutis (ARQT) is a clinical-stage biotech (dermatology). This indicator (`Short_All`) is a mirror of market fear. When it rises, investors panic and dump risk, especially unprofitable biotechs. This pessimism, visible on the chart, deprives ARQT of access to the capital needed for expensive trials.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Arcutis Biotherapeutics (ARQT)
Arcutis Biotherapeutics specializes in dermatology, bringing new treatments for skin diseases to market. Sales growth is important for the commercial stage of biotech. This chart measures the strength of market expectations for these sales. It shows when investors are overly optimistic (overbought) about a new drug or overly disappointed (oversold) by the report.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Arcutis-Biotherapeutics-ARQT&v=1772513861217 "RSI 14 indicator chart for the company's stock Arcutis Biotherapeutics (ARQT)")
RSI 14 Market Segment - Pharma skin
Arcutis Biotherapeutics is a biopharmaceutical company focused on dermatology. They develop and commercialize innovative treatments for skin conditions such as psoriasis and atopic dermatitis. This chart reflects the overall sentiment in the biotech sector. It helps assess how the market views this speculative industry as a whole and how Arcutis stands out.
RSI 14 for the overall market
Arcutis Biotherapeutics (ARQT) is a biotech company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria offers the potential to easily raise hundreds of millions of dollars for research. Market panic risks running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast ARQT (Arcutis Biotherapeutics)
Arcutis (ARQT) is a biopharmaceutical company focused on treating dermatological conditions such as psoriasis. This chart reflects the average price target from analysts. It shows their collective forecast for the commercial success of the company's new drug launches and market share gains in a competitive market.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-ARQT-Arcutis-Biotherapeutics&v=1772513861240 "A chart showing analyst consensus forecasts for the expected stock price. ARQT (Arcutis Biotherapeutics)")
The difference between the consensus estimate and the actual stock price ARQT (Arcutis Biotherapeutics)
Arcutis is a biopharmaceutical company focused on dermatology (treating skin conditions such as psoriasis). This chart shows the difference between the consensus estimate and the price. It reflects analysts' confidence in the commercial success of its approved drugs (Zoryve) and its R&D pipeline, seeing potential in them.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-ARQT-Arcutis-Biotherapeutics&v=1772513861252 "A chart showing the difference between the consensus forecast and the actual stock price. ARQT (Arcutis Biotherapeutics)")
Analyst consensus forecast for stock prices by market segment - Pharma skin
Arcutis Biotherapeutics is a dermatology company that developed and markets Zoryve, a non-hormonal cream for the treatment of psoriasis and seborrheic dermatitis. This chart shows analysts' overall expectations for the skin pharmaceutical sector. It reflects whether experts believe the new brand will be commercially successful in a competitive market.
Analysts' consensus forecast for the overall market share price
Arcutis Biotherapeutics is a biopharmaceutical company specializing in developing treatments for dermatological diseases such as psoriasis and atopic dermatitis. This chart shows the overall risk appetite in the market. For Arcutis, like many biotechs whose value depends on the success of clinical trials, overall optimism (risk appetite) is important for attracting the capital needed for research.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Arcutis Biotherapeutics
Arcutis Biotherapeutics is a biotech company focused exclusively on dermatology (the treatment of skin diseases). Their strategy is not to invent new molecules, but to improve existing drugs, making them more effective and convenient (for example, Zoryve). This chart is a comprehensive assessment of their commercial launch. It measures the pace of their drug adoption and their ability to compete with big pharma.
AKIMA Market Segment Index - Pharma skin
Arcutis Bio is a biotech focused on dermatology (skin diseases); the company successfully launched Zoryve (cream) for the treatment of psoriasis and dermatitis. This summary metric evaluates R&D. The graph shows the average value for the segment. This benchmark: how does this niche (dermatology) model differentiate Arcutis from the average pharma company?
The AKIM Index for the overall market
Arcutis is a commercial-stage biotech company focused on dermatology. It develops and markets creams (Zoryve) for the treatment of psoriasis and dermatitis. This chart, which reflects the market average, provides a macro backdrop. It helps assess how this product launch story in a non-cyclical sector compares to the overall economic trends affecting markets.
